News

Eli Lilly’s Mounjaro shows cardiovascular gains, but analysts underwhelmed
Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.
PharmExec7h
Eli Lilly and Company’s Mounjaro Displayed Cardiovascular Protection in New Head-to-Head Trial
Eli Lilly's Mounjaro shows significant cardiovascular benefits in a major trial enhancing treatment options for type 2 ...
The Pharma Letter7h
Lilly's Mounjaro demonstrates cardiovascular protection
US pharma major Eli Lilly has announced top-line results from SURPASS-CVOT, a first-of-its-kind head-to-head Phase III ...
Lilly stock falls as Mounjaro fails to show superiority over Trulicity
Eli Lilly and Company (NYSE:LLY) stock fell on Thursday morning after the pharmaceutical giant’s diabetes drug Mounjaro ...
Devdiscourse1d
Mounjaro Overshadows Trulicity in Life-Saving Diabetes Battle
Eli Lilly's Mounjaro diabetes drug has demonstrated superior performance over Trulicity in reducing heart attack and stroke ...
I lost 9st on Mounjaro but was losing hair in clumps – I found a surprising solution that stylists don’t usually suggest
A MUM who lost a staggering nine stone on a weight-loss jab says her hair started falling out in clumps, until she found an ...
Mounjaro boobs? Weight loss drug can shrink breast cancer tumors, says new study
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...